Article: | MedLuna.com

Overview

Journal Adv Lab Med

Publisher De Gruyter

Specialty Biochemistry

Date 2024 Apr 18

PMID 38634083

Authors

Maria Luisa Gonzalez-Casaus

Affiliations

Soon will be listed here.

References

Loh N, Neville M, Marinou K, Hardcastle S, Fielding B, Duncan E . LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion. Cell Metab. 2015; 21(2):262-273. PMC: 4321886. DOI: 10.1016/j.cmet.2015.01.009. View

McDonald M, Khoo W, Ng P, Xiao Y, Zamerli J, Thatcher P . Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell. 2021; 184(5):1330-1347.e13. PMC: 7938889. DOI: 10.1016/j.cell.2021.02.002. View

Jaberi S, Cohen A, DSouza C, Abdulrazzaq Y, Ojha S, Bastaki S . Lipocalin-2: Structure, function, distribution and role in metabolic disorders. Biomed Pharmacother. 2021; 142:112002. DOI: 10.1016/j.biopha.2021.112002. View

Brandenburg V, Verhulst A, Babler A, DHaese P, Evenepoel P, Kaesler N . Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!. Nephrol Dial Transplant. 2018; 34(3):408-414. DOI: 10.1093/ndt/gfy129. View

Wang J, Mazur C, Wein M . Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones. Front Endocrinol (Lausanne). 2021; 12:584147. PMC: 7988212. DOI: 10.3389/fendo.2021.584147. View

Kim S, Da H, Li Z, Kushwaha P, Beil C, Mei L . Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism. J Biol Chem. 2019; 294(17):6899-6911. PMC: 6497967. DOI: 10.1074/jbc.RA118.006769. View

Bolland M, Grey A, Horne A, Reid I . Testosterone levels following decreases in serum osteocalcin. Calcif Tissue Int. 2013; 93(2):133-6. DOI: 10.1007/s00223-013-9730-x. View

Brandenburg V, Kramann R, Koos R, Kruger T, Schurgers L, Muhlenbruch G . Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study. BMC Nephrol. 2013; 14:219. PMC: 3851854. DOI: 10.1186/1471-2369-14-219. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

10.

Galea G, Meakin L, Sugiyama T, Zebda N, Sunters A, Taipaleenmaki H . Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. J Biol Chem. 2013; 288(13):9035-48. PMC: 3610976. DOI: 10.1074/jbc.M112.405456. View

11.

Dreyer T, Keen J, Wells L, Roberts S . Novel insights on the effect of sclerostin on bone and other organs. J Endocrinol. 2023; 257(2). DOI: 10.1530/JOE-22-0209. View

12.

Hofbauer L, Schoppet M . Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004; 292(4):490-5. DOI: 10.1001/jama.292.4.490. View

13.

Sabbagh Y, Graciolli F, OBrien S, Tang W, Dos Reis L, Ryan S . Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res. 2012; 27(8):1757-72. DOI: 10.1002/jbmr.1630. View

14.

Iwamoto R, Koide M, Udagawa N, Kobayashi Y . Positive and Negative Regulators of Sclerostin Expression. Int J Mol Sci. 2022; 23(9). PMC: 9102037. DOI: 10.3390/ijms23094895. View

15.

Kikuchi A, Kishida S, Yamamoto H . Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med. 2006; 38(1):1-10. DOI: 10.1038/emm.2006.1. View

16.

Lin X, Brennan-Speranza T, Levinger I, Yeap B . Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity. Nutrients. 2018; 10(7). PMC: 6073619. DOI: 10.3390/nu10070847. View

17.

Roforth M, Fujita K, McGregor U, Kirmani S, McCready L, Peterson J . Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans. Bone. 2013; 59:1-6. PMC: 3877168. DOI: 10.1016/j.bone.2013.10.019. View

18.

Lee N, Sowa H, Hinoi E, Ferron M, Ahn J, Confavreux C . Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456-69. PMC: 2013746. DOI: 10.1016/j.cell.2007.05.047. View

19.

Nealy K, Harris K . Romosozumab: A Novel Injectable Sclerostin Inhibitor With Anabolic and Antiresorptive Effects for Osteoporosis. Ann Pharmacother. 2020; 55(5):677-686. DOI: 10.1177/1060028020952764. View

20.

Yang L, Wang J, Gong X, Fan Q, Yang X, Cui Y . Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis. Front Genet. 2022; 12:728827. PMC: 8819683. DOI: 10.3389/fgene.2021.728827. View